Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2006; 131(33): 1809-1812
DOI: 10.1055/s-2006-949159
DOI: 10.1055/s-2006-949159
Prinzip & Perspektive | Review article
Onkologie/Grundlagenforschung
© Georg Thieme Verlag KG Stuttgart · New York
Identifizierung von Tumorantigenen: Strategien und Perspektiven
Identification of tumor antigens: strategies and perspectivesFurther Information
Publication History
eingereicht: 1.3.2006
akzeptiert: 18.5.2006
Publication Date:
11 August 2006 (online)
Schlüsselwörter
Tumorantigen - Immuntherapie - tumorspezifische Immunantwort
Key words
tumor antigen - immuntherapy - tumor-specific immune response
Literatur
- 1 Jäger D, Taverna C, Zippelius A, Knuth A. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol Immunother. 2004; 53 144-147
- 2 Boon T, Coulie P G, Van den Eynde B. Tumor antigens recognized by T cells. Immunology Today. 1997; 18 267-268
- 3 Simpson A JG, Caballero O L, Jungbluth A, Chen Y T, Old L J. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005; 5 615-625
- 4 Jäger E, Jager D, Knuth A. Antigen-specific immunotherapy and cancer vaccines. Int J Cancer. 2003; 160 817-820
- 5 Zippelius A, Batard P, Rubio-Godoy V. et al . Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res. 2004; 64 2865-2873
Dr. med. Alfred Zippelius
Klinik und Poliklinik für Onkologie, Departement für Innere Medizin, UniversitätsSpital Zürich
Rämistraße 100
CH-8091 Zürich
Phone: 0041/44/2559414
Fax: 0041/44/2554548
Email: alfred.zippelius@usz.ch